SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.

Altre lingue Suzhou Fushilai Pharmaceutical Co., Ltd.

Azioni

301258

CNE1000058W2

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 09/07/2024			Variaz. 5gg	Var. 1 gen.
24,3 ^CNY	+1,25%		-5,59%	-24,72%

05/06	Suzhou Fushilai Pharmaceutical Co., Ltd. annuncia l'attuazione del piano di distribuzione finale degli utili (Azioni A) per il 2023, pagabile il 12 giugno 2024	CI
22/04	Suzhou Fushilai Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	01/07
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Implementation of Final Profit Distribution Plan (A Shares) for 2023, Payable on 12 June 2024	05/06
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	01/04
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	29/03
Suzhou Fushilai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	06/02
Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	05/02
Fushilai Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Suzhou Fushilai Pharmaceutical Co., Ltd.	18/12
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	19/10/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21/08/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable on 08 June 2023	01/06/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022	10/05/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	18/04/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2023.	29/03/23
Fushilai Pharmaceutical to Apply for 375 Million Yuan Credit Lines This Year	16/03/23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves Management Appointments	13/09/22
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Suzhou Fushilai Pharmaceutical Co., Ltd.

Azioni

301258

CNE1000058W2

Altre lingue

Filtri